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Background: Korean Red Ginseng (KRG) is a herbal medicine used in Asian countries and is very popular
for its beneﬁcial biological properties. Diabetes mellitus (DM) and its complications are rapidly becoming
a global public health concern. The literature on transcriptional changes induced by KRG in rat models of
diabetic retinopathy is limited. Considering these facts, we designed this study to determine whether
retinopathy-associated genes are altered in retinas of rats with DM and whether the induced changes are
reversed by KRG.
Methods: Male SpragueeDawley rats were intravenously injected with streptozotocin (50 mg/kg body
weight) to induce DM, following which, KRG powder (200 mg/kg body weight) was orally administered
to the KRG-treated DM rat group for 10 wks. The rats were then sacriﬁced, and their retinas were har-
vested for total RNA extraction. Microarray gene expression proﬁling was performed on the extracted
RNA samples.
Results: From among > 31,000 genes investigated, the expression of 268 genes was observed to be
upregulated and that of 58 genes was downregulated, with twofold altered expression levels in the DM
group compared with those in the control group. Moreover, 39 genes were upregulated more than
twofold and 84 genes were downregulated in the KRG-treated group compared to the DM group. The
expression of the genes was signiﬁcantly reversed by KRG treatment; some of these genes were analyzed
further to verify the results of the microarray experiments.
Conclusion: Taken together, our data suggest that reversed changes in the gene expression may mediate
alleviating activities of KRG in rats with diabetic retinopathy.
Copyright  2015, The Korean Society of Ginseng, Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A dramatic increase in the total number of patients with dia-
betes worldwide shows that diabetes mellitus (DM) and its com-
plications are rapidly becoming a major global public health
concern. Every individual with DM is considered to be at risk of
developing diabetic retinopathy (DR). DR is a diabetic complication
that affects the blood vessels and causes death of retinal cells, ul-
timately leading to blindness [1,2]. Indeed, DR is the most impor-
tant cause of blindness occurring in working-age adults, and it is
also the common microvascular complication of DM [3]. The retina
consists of multiple layers of retinal cells. Loss of cells from the
various retinal layers seems to be a prominent feature of DR. Pre-
vious researchers observed DM-induced cell death in all retinaly, School of Medicine, Kyung Hee
ht  2015, The Korean Society of G
c-nd/4.0/).layers, implying that several types of retinal cells may be affected by
DM [4e7]. Understanding the retinal changes occurring during DM
and developing new drug candidates are important for designing
effective therapies for DR treatment. The precise mechanism of DR
is not completely understood. However, it is believed that various
factors such as oxidative stress, inﬂammation, cell death, and ge-
netic and metabolic alterations are involved in the development
and progression of DM and DR.
Panax ginseng Mayer has been a popular herbal medicine in
Eastern Asia for > 2,000 years. Recent studies have demonstrated
various effects of ginseng, including antioxidant, antithrombotic,
antihyperlipidemic, angiogenic, and anticancer effects [8e12].
Korean Red Ginseng (KRG), produced by repeated heating and
drying of the root of ginseng, has strong potent pharmacologicalUniversity, #1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, Korea.
inseng, Published by Elsevier Ltd. This is an open access article under the CC BY-NC-
Table 1
Primer for real-time polymerase chain reaction
Gene symbol Primer sequence Size
Crygb F AATGTAATGGAGGGCTGCTG 124
R AGCCAACTTTGGCGTTTG
Gfap F TTGGCTCTGAATCCTTGGAA 135
R GGGACTGAGCAACCAGGATA
Igf1r F CCCTACCCAAACCCTTAACTG 179
R CACTGGGAAGCGGAGAAA
Gapdh F ATGATTCTACCCACGGCAAG 89
R CTGGAAGATGGTGATGGGTT
J Ginseng Res 2016;40:1e82actions effective in the treatment of several human diseases. In DM,
KRG not only improves glucose control but also enhances the renal,
auditory, and immune functions [13e17].
Microarrays are high-throughput genomic tools that offer the
fastest and most comprehensive molecular evaluations [18]. Over
the past few years, microarrays have been used to compare the
global changes in gene expression proﬁles to enable researchers
investigate the molecular and functional alterations of genes in
human diseases such as DM [19e22].
In the current study, the systematic analysis of gene expression
proﬁling was performed in the retinal tissues of rats with strepto-
zotocin (STZ)-induced diabetes before and after KRG treatment to
identify the mechanism for the mitigating effect of KRG on
retinopathy.
2. Materials and methods
2.1. Animals
Seven-wk-old male SpragueeDawley (SD) rats were housed un-
der a 12 h:12 h light-dark cycle at room temperature. All the ratswere
allowed water ad libitum. The rats were divided into normal control,
DM, and KRG-treated DM groups. The rats were injected intrave-
nously with a single dose of STZ (50 mg/kg body weight; Sigma-
Aldrich Corporation, St. Louis, MO, USA). STZ was dissolved in 0.01M
of sodiumcitrate buffer (pH 4.5), kept on an ice bath, and usedwithin
15min of preparation. The control ratswere injectedwith the vehicle
only. Two days after STZ administration, only the rats with a blood
glucose level of > 300 mg/dL were considered to have diabetes and
included in further experiments. KRG powder was obtained from the
Korea Ginseng Corporation (Daejeon, Korea). The general composi-
tion of the KRG powder was as follows: moisture 36%, solid volume
64%, ash 2.5%, total fat 0.05%, total crude saponin 70 mg/g, and total
ginsenosides 20 mg/g. The rats in the KRG-treated group received
KRGmixed into powdered food at aﬁnal concentration of 200mg/kg/
d for 10 wk. The control and DM groups received powdered food
alone. In all the groups, > 95% of food was consumed, implying that
the rats received the intended doses of KRG.
2.2. Sample preparation
Total RNA was extracted from rat retinal cells by using the
miRNeasy Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. The total RNA pellet was dissolved in
diethylpyrocarbonate water, and its quality and quantity was
analyzed using the Bioanalyzer 2100 System (Agilent Technologies,
Palo Alto, CA, USA). Gene expression was analyzed using the Gen-
eChip Rat Genome 230 2.0 Arrays (Affymetrix, Santa Clara, CA,
USA), which comprises > 31,000 probe sets representing approxi-
mately 28,700 characterized rat genes. For each gene, 11 pairs of
oligonucleotide probes were synthesized in situ on the arrays.
2.3. Microarray
Biotinylated complementary RNAs were prepared from 500 ng
total RNA, according to the standard Affymetrix protocol. Brieﬂy,
following fragmentation, 15 mg of artiﬁcial RNA (aRNA) was hybrid-
ized for 16 h at 45C on the GeneChip Rat Genome Array (Affyme-
trix). The GeneChips were washed and stained in the Fluidics Station
450 (Affymetrix) and then scanned by using the GeneChip Scanner
3000 7G (Affymetrix). The data obtained were analyzed by using the
Robust Multichip Analysis (RMA) algorithm with Affymetrix default
analysis settings and global scaling as the normalizationmethod. The
trimmed mean target intensity of each array was arbitrarily set to
100. The normalized and log-transformed intensity values were thenanalyzed using GeneSpring GX 12.6.1 (Agilent Technologies). Fold-
change ﬁlters were set to retain only upregulated genes present in
 200% of the controls and downregulated genes present in< 50% of
the controls. Hierarchical clustering data were grouped according to
similarity in behavior across the experiments by using GeneSpring
GX 12.6.1. Clustering algorithmwas based on the euclidean distance
and average linkage.
2.4. Complementary DNA synthesis
The total amount of the extracted RNA was determined spec-
trophotometrically at 260/280 nm. The RNA quality was assessed as
the absence of smear of 18S and 28S bands by using Bioanalyzer
2100. RNA samples were stored at 70C until further use. Com-
plementary DNAs (cDNAs) were synthesized from 1 mg of total RNA
by using the High-Capacity RNA-to-cDNA Kit (Applied Biosystems),
according to the manufacturer’s protocol.
2.5. Real-time quantitative polymerase chain reaction
High-throughput real-time quantitative polymerase chain reac-
tion (RT-qPCR) was performed using the Applied Biosystems Prism
7900 Sequence Detection System (PE Applied Biosystems, www.
appliedbiosciences.com) in triplicates by using white-colored 384-
well plates (ABgene, Hamburg, Germany) for intensifying the ﬂuo-
rescent signals by a factor of three. This system operates using a
thermal cycler and a ﬁberoptics-directed laser to each of the 384
wells. Theﬂuorescence emission fromeachwellwas collectedusing a
charge-coupled device-camera, and the quantitative data were
analyzed by using the Sequence Detection System Software (SDS
version 2.2, PE Applied Biosystems). PCR primer sequences used in
this study are given in Table 1. The reaction mixtures contained
10 pmol/mL of each primer and 2X SYBR Green PCR Master Mix (PE
Applied Biosystems), which contains the HotStarTaq DNA-
Polymerase in an optimized buffer, the Deoxynucleotide (dNTP) mix
(with Deoxyuridine triphosphate, dUTP additive), the SYBRs Green I
ﬂuorescent dye, and the ROX dye as a passive reference. To each well
of the 384-well RT-qPCR plates, serial dilutions (1, 1=2, 1=4, 1=8, and
1=16)of cDNAwere added,whichwere thenused to generate relative
standard curves for the genes. All the primers were ampliﬁed using
the same conditions: thermal cycling at 50C for 2 min and 95C for
10 min, followed by 40 cycles of 95C for 30 s and 60C for 30 s, and
ﬁnally at 72C for 3 s. In order to exclude the presence of unspeciﬁc
products, a melting curve analysis of the products was performed
routinelyafterampliﬁcationviahigh-resolutiondatacollectionwitha
temperature increase from 60C to 95C, and with a ramp rate of
0.21C/s. Then, the RT-qPCR cycle numbers were converted to the
corresponding gene amounts (ng) on the basis of the equation.
2.6. Statistical analysis
Statistical signiﬁcance between each group was estimated by
Student t test, and the results were expressed as mean  standard
H. Yang et al / mRNA expression of diabetic retina 3deviation (GraphPad Prism version 4; GraphPad Software, San
Diego, CA, USA).
3. Results and discussion
3.1. Establishment of diabetic rat model
During the experiment, rats with diabetes gradually lost their
body mass and developed high blood glucose levels. Two days after
DM onset, the average blood glucose level in the DM group was >
450 mg/dL; this level persisted with the progress of DM within
450e600 mg/dL range.
Prior to the microarray study, the effect of KRG on the
biochemical indicators in the rats with STZ-induced DM was
determined. The rats with KRG-treated DM did not show any
change in body weight, plasma glucose, and hemoglobin A1c
(HbA1c) levels as compared with those in rats with STZ-induced
DM, suggesting that KRG has little effect on DM (Figs. 1AeC). The
results, however, suggest that oral administration of KRG can lower
the average levels of triglyceride and cholesterol in rats with KRG-
treated DM than in rats with STZ-induced DM, although the dif-
ference in the levels is not statistically signiﬁcant (Figs. 1D, 1E).
Abnormalities of plasma lipid and lipoprotein concentrations
are common in DM. Patients with DM showed reduced plasmaFig. 1. Changes in body weight and the serum biochigh-density lipoprotein (HDL) cholesterol and increased plasma
triglyceride and low-density lipoprotein (LDL) cholesterol levels
[23], which are strongly correlated with cardiovascular complica-
tions [24,25]. Furthermore, it has been reported that abnormal
serum lipid levels in patients with DM can be restored by admin-
istration of antidiabetic agents to the patients [26,27]. These results
suggest that KRG exerts hypolipidemic effects in rats with estab-
lished STZ-induced DM.
3.2. Identiﬁcation of global gene expression changes
Findings from a previous study have suggested the ameliorating
effect of alcoholic ginseng extract on diabetic complications, which
demonstrated biochemical and functional changes in mouse retina
and heart [28]. Accordingly, we explored global changes in gene
expression to attempt systemic analysis of the effect of KRG on
diabetic retinopathy.
Total RNAs extracted from rat retinal cells were analyzed using
the whole rat genomemicroarray. To obtain a rough estimate of the
number of patterns between DM and KRGþDM groups, we per-
formed hierarchical clustering. In Fig. 2, red color indicates over-
expression and green color indicates underexpression of genes. A
total of 326 genes were differentially expressed in the DM rat
retinal cells than in the control cells, of which 268 genes showedhemical parameters in different groups of rats.
Fig. 2. Hierarchical cluster image showing the differential gene expression proﬁles in
DM and DMþKRG group. Gene expression levels of normal control rats are shown in
black for base-lines; upregulated genes are shown in red color, whereas down-
regulated genes are shown in green color. DM, diabetes mellitus; KRG, Korean Red
Ginseng.
J Ginseng Res 2016;40:1e84upregulated expression and 58 genes showed more than twofold
downregulated expression. In the retina of KRG-treated DM rats,
the expressions of 39 genes were upregulated and of 84 genes were
downregulated as compared with those in the retina of rats with
DM (Table 2). Thus, we observed a reversal of the pattern of the
number of differentially expressed genes in the DM rat retinal cells
by KRG treatment.
3.3. Functional classiﬁcation of genes
The differentially expressed genes were divided into the
following 19 functional groups: apoptosis, behavior, cell adhesion,
cell communication, cell cycle, cell development, cell differentia-
tion, cell migration, cell proliferation, growth, homeostasis, in-
ﬂammatory response, immune response, lipid metabolism,
response to stress, signal transduction, transcription, translation,
and transport. The number of genes of DM and DMþKRG rat retina
in each category is shown in Fig. 3A and 3B, respectively. As Fig. 3B
displays, the number of genes altered in Fig. 3A showed a reversed
pattern after KRG treatment, which indicates that the change in theTable 2
The number of differentially expressed genes in retina of rats with diabetes before
and after treatments of Korean Red Ginseng
Control vs. DM DM vs. DMþKRG
Upregulated genes 268 39
Downregulated genes 58 84
DM, diabetes mellitus; KRG, Korean Red Ginseng.expression of genes induced by DM may be restored by KRG
treatment. These data revealed that KRG may play roles in different
biological pathways in DR and that some of the genes involved in
these pathways are fairly responsive to KRG treatment.
3.4. Effect of KRG in restoration of gene expression altered in DM
Ginseng is currently one of the most famous herbal medicines in
the world, which is well known to be beneﬁcial in the treatment of
various diseases such as cancer, cardiovascular diseases, and DM.
KRG, prepared by the traditional method of steaming and sun
drying ginseng, has better pharmacological activities such as anti-
oxidant, anti-inﬂammatory, anticarcinogenic, and ameliorative ef-
fects on blood circulation as compared to white ginseng prepared
by only sun drying fresh ginseng [29]. On using high pressure and
temperature during KRG preparation, the total phenolic and
ﬂavonoid content increases and some ginsenosides (the major
active ingredients of KRG) are newly produced [30,31]. These
components of ginseng have been reported to modulate the gene
expression [32,33].
In our experiment, numerous genes differentially expressed in
DM rat retinal cells showed signiﬁcant reversals by KRG treatment
(Table 3). Altered genes in DM raise the possibility that these
changes contribute to the pathogenesis of retinopathy. Indeed, the
results involved several genes related to the development and
progression of retinopathy, such as Cd47 (or integrin-associated
protein; IAP), Cyp26a1, Igf1r, Litaf, and Mmp14. Moreover, the
markers of retinopathy, such as Gfap, Crystallin, and Hmox1, were
also identiﬁed. Hmox1 is known as an antioxidant gene mediating
an adaptive response under pathophysiologic conditions, such as
vascular disease [34]. Although blood glucose level was unaffected
by KRG administration in this experiment, a number of genes
showed changes in their expression, which suggests more mech-
anisms, such as a direct modulation by components in KRG on gene
expression.
We employed the Database for Annotation, Visualization, and
Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/) tools to
analyze the gene ontology (GO) of selected genes, which allows
enrichment of functional genes. We observed a range of degrees of
GO term enrichments in a selected gene set (Table 4). Among the
identiﬁed categories, most genes belonged to the intracellular
signaling group. Several other selected genes were also related to
cell death and apoptosis. These results indicate that the reversed
expression of genesmediate alleviating effect of KRG by inﬂuencing
various cell signals and retinal cell death during DM.
Taken together, our results demonstrate that the expression
levels of numerous genes are signiﬁcantly altered by KRG treatment
in retinal cells of rats with DM; thus, they can be considered to be
directly or indirectly associated with the alleviating activity of KRG
toward diabetic complications.
3.5. Validation of microarray data
To conﬁrm the reliability of the microarray data, the expression
of three differentially expressed genes, Gfap, Igf1r, and Crygb,
related to retinopathy was analyzed by performing RT-qPCR. The
expression levels of these three genes from retinal cells of rats with
DMwere upregulated as compared to those from control rat retinal
cells, whereas they were decreased in the retinal cells of rats with
KRG-treated DM (Fig. 4).
Glial ﬁbrillary acidic protein (GFAP) is a representative marker
associated with polyol pathway in diabetic retinopathy [7]. In dia-
betic retina, GFAP is upregulated, indicating dysfunction and
structural abnormalities of Müller cells [35]. Insulin-like growth
factor 1 receptor (IGF1R) is also increased in retinas of rats with DM
Fig. 3. Functional classiﬁcation of differentially expressed genes. Differentially expressed genes in (A) DM group compared with the control group or (B) DMþKRG group compared
with DM group were classiﬁed into 19 groups and the numbers of genes in each group were shown as the graph. Red and blue bars indicate the number of upregulated ( 2.0) and
downregulated ( 0.5) genes, respectively. DM, diabetes mellitus; KRG, Korean Red Ginseng.
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Kuang et al [37] reported that reduced IGF1R immunoreactivity by
using IGF-1 analogue can prevent predegenerative changes asso-
ciated with the progression of DR, despite existence of sustainedFig. 4. Analysis of the relative expression of differentially expressed genes by real-time qua
and Crygb messenger RNA levels by real-time quantitative PCR, as described in the Mater
independent experiments. *p > 0.005.hyperglycemia. In our study, several subunits of crystallin showed
greatly altered expression between DM and DMþKRG rat groups
(Table 3). Crystallin acts as a small heat shock protein in the retina
in response to stress, rather than as a structural protein [38]. It isntitative polymerase chain reaction (PCR). Retina tissues were analyzed for Gfap, Igf1r,
ials and methods section. Data are expressed as mean  standard deviation of three
Table 3
List of genes showing reversed expression by Korean Red Ginseng in retina of rats with diabetes
Description Gene symbol Fold change(DM/Con) Fold change(DMþKRG/DM)
Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 5.704 0.336
Adfp Adipose differentiation related protein 3.888 0.284
Aldh3a1 Aldehyde dehydrogenase 3 family, member A1 10.476 0.421
Alox5ap Arachidonate 5-lipoxygenase activating protein 2.694 0.334
Bcl3 B-cell CLL/lymphoma 3 3.228 0.412
Bfsp1 Beaded ﬁlament structural protein 1 47.469 0.481
Birc7 Baculoviral IAP repeat-containing 7 4.274 0.312
C1qb Complement component 1, q subcomponent, B chain 2.234 0.486
C1qc Complement component 1, q subcomponent, C chain 3.839 0.455
Ccnd2 Cyclin D2 2.713 0.388
Cd47 Cd47 molecule 2.248 0.495
Cidea Cell death-inducing DFFA-like effector a 10.025 0.483
Copg2 Coatomer protein complex, subunit gamma 2 3.392 0.322
Crip Cysteine-rich intestinal protein 2.590 0.499
Cryga Crystallin, gamma A 4.765 0.368
Crygb Crystallin, gamma B 62.504 0.397
Crygc Crystallin, gamma C 78.570 0.483
Crygd Crystallin, gamma D 83.967 0.415
Cryge Crystallin, gamma E 5.100 0.301
Cyp26a1 Cytochrome P450, family 26, subfamily a, polypeptide 1 2.749 0.483
Dclk1 Doublecortin-like kinase 1 4.700 0.330
Dennd4a DENN/MADD domain containing 4A 2.161 0.445
Edn2 Endothelin 2 10.581 0.208
Emp1 Epithelial membrane protein 1 4.698 0.357
Fancb Fanconi anemia, complementation group B 4.804 0.386
Fcgr2a Fc fragment of IgG, low afﬁnity IIa, receptor 2.190 0.468
Fgl2 Fibrinogen-like 2 4.665 0.492
Gadd45g Growth arrest and DNA-damage-inducible, gamma 3.838 0.345
Gal Galanin prepropeptide 3.789 0.205
Gfap Glial ﬁbrillary acidic protein 12.043 0.482
Gnb3 Guanine nucleotide binding protein (G protein), beta polypeptide 3 2.735 0.382
Gpnmb Glycoprotein (transmembrane) nmb 10.825 0.483
Hmox1 Heme oxygenase (decycling) 1 4.906 0.500
Igf1r Insulin-like growth factor 1 receptor 2.000 0.490
Il4ra Interleukin 4 receptor, alpha 2.750 0.252
Inmt Indolethylamine N-methyltransferase 2.487 0.442
Irak2 Interleukin-1 receptor-associated kinase 2 2.669 0.210
Kif11 Kinesin family member 11 2.152 0.339
Klf10 Kruppel-like factor 10 2.202 0.378
Krt12 Keratin 12 41.472 0.263
Krt18 Keratin 18 3.840 0.343
Krt6a Similar to keratin complex 2, basic, gene 6a 3.399 0.351
Lcn2 Lipocalin 2 16.957 0.434
Lgals3 Lectin, galactoside-binding, soluble, 3 40.062 0.372
Litaf Lipopolysaccharide-induced TNF factor 4.198 0.441
Lypd2 Ly6/Plaur domain containing 2 7.488 0.297
Matn2 Matrilin 2 3.221 0.468
Mlf1 Myeloid leukemia factor 1 3.459 0.124
Mmp14 Matrix metallopeptidase 14 (membrane-inserted) 2.255 0.487
Mt1a Metallothionein 1a 10.301 0.493
Mt2A Metallothionein 2A 18.029 0.433
Muc3a Mucin 3A, cell surface associated 2.430 0.131
Pdpn Podoplanin 3.687 0.430
Plekha8 Pleckstrin homology domain containing, family A
(phosphoinositide binding speciﬁc) member 8
2.313 0.396
Postn Periostin, osteoblast speciﬁc factor 2.090 0.387
Prtg Protogenin homolog (Gallus gallus) 5.292 0.377
S100a3 S100 calcium binding protein A3 3.271 0.269
Samd4a Sterile alpha motif domain containing 4A 4.179 0.487
Sec16b SEC16 homolog B (Saccharomyces cerevisiae) 2.733 0.457
Serpina3n Serine (or cysteine) peptidase inhibitor, clade A, member 3N 7.249 0.368
Slc25a30 Solute carrier family 25, member 30 2.251 0.348
Slc26a8 Solute carrier family 26, member 8 3.966 0.273
Stat3 Signal transducer and activator of transcription 3 3.115 0.397
Stc1 Stanniocalcin 1 2.472 0.497
Tagln2 Transgelin 2 3.708 0.461
Tbata Thymus, brain and testes associated 2.623 0.468
Timp1 TIMP metallopeptidase inhibitor 1 11.742 0.282
Tmbim1 Transmembrane BAX inhibitor motif containing 1 5.420 0.388
Tmod1 Tropomodulin 1 3.865 0.407
Cdr2 Cerebellar degeneration-related 2 0.325 2.300
Grk1 G protein-coupled receptor kinase 1 0.409 2.307
Herc3 Hect domain and RLD 3 0.413 2.341
Id3 Inhibitor of DNA binding 3 0.574 2.263
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Table 3 (continued )
Description Gene symbol Fold change(DM/Con) Fold change(DMþKRG/DM)
Lamb3 Laminin, beta 3 0.200 2.333
LOC689064 Beta-globin 0.264 2.262
Pax4 Paired box 4 0.436 4.471
Pla2r1 Phospholipase A2 receptor 1 0.408 2.520
Prc1 Protein regulator of cytokinesis 1 0.317 3.163
RT1-S3 RT1 class Ib, locus S3 0.449 2.086
Sntg2 Syntrophin, gamma 2 0.449 2.489
Tmem116 Transmembrane protein 116 0.439 2.533
Trove2 TROVE domain family, member 2 0.473 2.066
Table 4
Overrepresented gene ontology biological process annotations associated with dif-
ferential expression of selected messenger RNAs using the DAVID tool
Term Count Fold p
GO0035556: intracellular signaling cascade 10 2.3 0.0091
GO0042981: regulation of apoptosis 9 2.9 0.0036
GO0043067: regulation of programmed
cell death
9 2.8 0.0039
GO0001654: eye development 8 12.3 <0.001
GO0007423: sensory organ development 8 7 <0.001
GO0009888: tissue development 8 2.8 0.0076
GO0043065: positive regulation of apoptosis 6 3.9 0.004
GO0043068: positive regulation of
programmed cell death
6 3.9 0.0042
GO0010942: positive regulation of cell death 6 3.9 0.0043
GO0043627: response to estrogen stimulus 5 7.3 <0.001
Database for Annotation, Visualization and Integrated Discovery (DAVID) tools were
used for gene ontology (GO) analysis. Results show the top 10 GO terms that are
signiﬁcantly overrepresented (fold change > 2 and p < 0.01, Fisher’s exact test) in
the selected messenger RNAs of retinas of rats with diabetes.
H. Yang et al / mRNA expression of diabetic retina 7reported that crystallins at both the protein and messenger RNA
(mRNA) levelswere highly upregulated in SD ratswith STZ-induced
diabetes [39,40], which is a hallmark of DM in the retina [41].
The consistency of RT-qPCR results with the microarray data
conﬁrmed the inﬂuence of KRG on the expression of the selected
genes. Furthermore, the data were consistent with the suggestion
that KRG may contribute to the mitigation of retinopathy by
altering the mRNA levels of retinopathy-related genes. Reversal of
gene expression after KRG treatment may provide a validation of
drug efﬁcacy. From this perspective, reversal of transcriptional
changes in KRG-treated rat retina implies that KRG can have ther-
apeutic effects on DR by modulating the expression levels of rele-
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